Venture Life Group PLC Director/PDMR Shareholding (3240N)
August 07 2017 - 11:24AM
UK Regulatory
TIDMVLG
RNS Number : 3240N
Venture Life Group PLC
07 August 2017
7 August 2017
Venture Life Group plc
("Venture Life" or "the Company")
Director/PDMR Shareholding
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the ageing population, announces that it was notified
on 7 August 2017 that Peter Bream, a Non-Executive Director of the
Company, has purchased 25,000 ordinary shares of 0.3p each in the
Company at an average price of 62.6p per share. Following the
transaction Mr Bream has a beneficial interest in 25,000 ordinary
shares representing 0.07 per cent. of the Company's issued share
capital.
Enquiries:
+44 (0) 1344
Venture Life Group PLC 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated Adviser +44 (0) 20
and Joint Broker) 3861 6625
Matthew Johnson / Edward Hutton / Margarita
Mitropoulou (Corporate Finance)
Bob Pountney / John Howes (Corporate
Broking)
+44 (0) 20
Turner Pope Investments (TPI) Ltd (Joint Broker) 3621 4120
James Pope / Ben Turner
Walbrook PR venturelife@walbrookpr.com
or
+ 44 (0) 20 7933 8780
Paul McManus / Anna Dunphy +44 (0) 7980 541 893 /
+44 (0) 7876 741 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the ageing population. The Group's product portfolio includes
some key products such as the UltraDEX oral care products range,
food supplements for lowering cholesterol and maintaining brain
function, medical devices for women's intimate healthcare and
haemorrhoids and dermo-cosmetics for addressing the signs of
ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies supplied by the Group's international distribution
partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the medical devices and cosmetic
sectors.
1 Details of the person discharging managerial responsibilities/person closely associated
--- ------------------------------------------------------------------------------------------------
a) Name Peter Bream
--- ------------------------------------------------------------ ----------------------------------
2 Reason for the notification
--- ------------------------------------------------------------------------------------------------
a) Position/status Director
--- ------------------------------------------------------------ ----------------------------------
b) Initial notification/ Amendment Initial notification
--- ------------------------------------------------------------ ----------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------------------------------------------
a) Name Venture Life Group plc
--- ------------------------------------------------------------ ----------------------------------
b) LEI
--- ------------------------------------------------------------ ----------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- ------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares of 0.3p each
Identification code GB00BFPM8908
--- ------------------------------------------------------------ ----------------------------------
b) Nature of the transactions Acquisition
--- ------------------------------------------------------------ ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
62p 15,000
63.5p 10,000
--- ------------------------------------------------------------ ----------------------------------
d) Aggregated information
- Aggregated volume 25,000
- Price 62.6p
---------------------------------------------------------------- ----------------------------------
e) Date of the transaction 7 August 2017
--- ------------------------------------------------------------ ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
--- ------------------------------------------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFFETLIDIID
(END) Dow Jones Newswires
August 07, 2017 11:24 ET (15:24 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2023 to Apr 2024